Evidence map›Paper›PMID 42352296›Full record

ArticleBiomolecules2026

Study on Formation of Phosvitin-Fructooligosaccharide Complex and Stability Improvement Mechanisms.

Anjia Huang, Jingyi Zhang, Shujie Chen, Yinlong Lian, Juan Chen, Xue Zhao, Chenggang Cai

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anjia HuangSchool of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.
Jingyi ZhangSchool of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.
Shujie ChenSchool of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.
Yinlong LianSchool of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.
Juan ChenSchool of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.
Xue ZhaoSchool of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.
Chenggang CaiSchool of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.ORCID 0000-0002-2614-6433

Funding

the National Key Research and Development Program of China during the 14th Five-Year Plan Period 2024YFF1106200Zhejiang Provincial "Three Rural Issues and Nine Parties" Science and Technology Cooperation Plan Project 2026SNJF008
6 · The paper itself

Abstract

Phosvitin (PV) is a highly phosphorylated protein with strong metal-chelating capacity and bioactivity, but its application is hindered by poor environmental stability. In this study, fructooligosaccharides (FOS) were introduced to form a PV-FOS composite system. The interaction mechanism and structural-functional changes were assessed via thermal and pH stability tests, molecular docking, FTIR, circular dichroism (CD), particle size, zeta potential and changes in turbidity. SDS-PAGE and changes in solubility confirmed the coexistence of PV and FOS in the composite system. Molecular docking revealed that FOS with varying degrees of polymerization can bind to PV through non-covalent interactions to form a complex. FTIR showed characteristic peaks of both components, with shifts and intensity changes at 3200-3500 cm

Indexed as

OligosaccharidesPhosvitinCircular DichroismHydrogen-Ion ConcentrationMolecular Docking SimulationParticle SizeSolubilitySpectroscopy, Fourier Transform InfraredfructooligosaccharideOligosaccharidesPhosvitinfructooligosaccharidesmolecular dockingnon-covalent interactionphosvitinstability

Identifiers

PMID42352296
PMCPMC13297318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.